Abstract
Purpose: To review the literature and to describe a case of bilateral anterior uveitis following systemic administration of moxifloxacin.
Methods: Narrative review of the literature and case report of a 45-year-old female who presented a bilateral conjunctival hyperemia, photophobia and pain after 15 days of treatment with systemic moxifloxacin due to an upper tract respiratory infection.
Results: at slit lamp examination, the patient presented an extensive iris transilumantion, presistent mydriasus, trabecular meshwork hyperpigmentation and secondary glaucoma.
Conclusion: moxifloxacion oral therapy may be responsible for bilateral anterior uveitis, iris transilumation and sphinter paralysis. This is the fith case described in Latin America and the second in Colombia.
Methods: Narrative review of the literature and case report of a 45-year-old female who presented a bilateral conjunctival hyperemia, photophobia and pain after 15 days of treatment with systemic moxifloxacin due to an upper tract respiratory infection.
Results: at slit lamp examination, the patient presented an extensive iris transilumantion, presistent mydriasus, trabecular meshwork hyperpigmentation and secondary glaucoma.
Conclusion: moxifloxacion oral therapy may be responsible for bilateral anterior uveitis, iris transilumation and sphinter paralysis. This is the fith case described in Latin America and the second in Colombia.
Translated title of the contribution | Secuelas graves de uveítis anterior bilateral no granulomatosa crónica secundaria al uso de moxifloxacina oral: Reporte de un caso |
---|---|
Original language | English |
Pages (from-to) | 1-14 |
Number of pages | 14 |
Journal | Ocular Immunology and Inflammation |
State | Submitted - Sep 20 2018 |